跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SM-4
首页
药物
SM-4
SM-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
一种盐酸伊伐布雷定及其中间体的制备方法
申请人: 江苏永安制药有限公司
优先权: 2022
CN
METHOD FOR DIAGNOSING AND TREATING COGNITIVE IMPAIRMENT AND USE THEREOF
申请人: BAO FENG BIOTECH BEIJING CO LTD
优先权: 2020
CN
US
2 件公开
Method for preparing paris polyphylla sm formula particles with antiasthmatic and antitussive effects and paris polyphylla sm formula particles prepared by using the method
申请人: JIANGXI QIANLONG PHARMACEUTICAL CO LTD
优先权: 2018
CN
Preparation method of litamilast intermediate
申请人: SHANGDONG NEW TIME PHARM PROD
优先权: 2023
CN
Preparation method of 4-(2, 6-dimethyl-3-nitropyridine-4-ylamino) phenethyl benzyl carbamate
申请人: LUOYANG HUIZHONG ANIMAL MEDICINE CO LTD
优先权: 2022
CN
Preparation method of olaparil intermediate
申请人: SHANGDONG NEW TIME PHARM PROD
优先权: 2023
CN
Synthetic method of fluorescent 2-aminopurine derivative
申请人: UNIV QINGDAO SCIENCE & TECHNOLOGY
优先权: 2025
CN
Catalyst for PO-SM process and preparation method thereof
申请人: RUNHE KEHUA CATALYST SHANGHAI CO LTD
优先权: 2023
CN
药物
反馈